Changes in the time-resolved fluoroimmunoassay of plasma enterolactone.
Stumpf
K
K
Institute for Preventive Medicine, Nutrition, and Cancer, Folkhälsan Research Center, Division of Clinical Chemistry, University of Helsinki, FIN-00014, Finland.
Uehara
M
M
Nurmi
T
T
Adlercreutz
H
H
D015107:4-Butyrolactone / Q000031:analogs & derivatives* / Q000097:blood; D000818:Animals; D004305:Dose-Response Relationship, Drug; D005063:Europium / Q000494:pharmacology; D015200:Fluoroimmunoassay / Q000379:methods*; D008401:Gas Chromatography-Mass Spectrometry; D006801:Humans; D006868:Hydrolysis; D017705:Lignans / Q000097:blood*; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D012908:Snails / Q000201:enzymology; D013429:Sulfatases / Q000494:pharmacology; D013997:Time Factors
D017705:Lignans; D005063:Europium; D013429:Sulfatases; D015107:4-Butyrolactone; C029497:2,3-bis(3'-hydroxybenzyl)butyrolactone